Japan COP and COC Syringe Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Disposable Syringes, and Reusable Syringes), By Application (Medical, Veterinary, Laboratory, and Others), By End-User (Hospitals, Clinics, Research Laboratories, and Others), and Japan COP and COC Syringe Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI12311
PAGES 220
REPORT FORMAT PathSoft

Japan COP and COC Syringe Market Insights Forecasts to 2035

  • The Japan COP and COC Syringe Market Size is Expected to Grow at a CAGR of 8.1% from 2025 to 2035
  • The Japan COP and COC Syringe Market Size is Expected to Hold a Significant Share by 2035

Japan COP and COC Syringe Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, the Japan COP and COC syringe market is expected to hold a significant share by 2035, at a CAGR of 8.1% during the forecast period 2025-2035. The market for COP (cyclic olefin polymer) and COC (cyclic olefin copolymer) syringes in Japan is growing, as it is fueled by the demand for high-end drug delivery systems, more resistant and chemically stable medical devices, and chronic diseases and precision medicine. The momentum also stems from innovations in syringe technology and the efforts towards safer, non-reactive injectables.

 

Market Overview

Japan COP (cyclo-olefin-polymer) and COC (cyclo-olefin-copolymer) syringe market refers to a vibrant category in the pharma and medical device sectors with a focus on high-performance disposable syringes produced from high-end thermoplastic polymers. Such syringes find major application in drug delivery, immunization, blood sampling, and aesthetic therapies and provide the benefits of transparency, chemical inertness, and break-resistance. COP and COC syringes are especially preferred for use with biologics and vaccines, including mRNA formats, due to they have excellent barrier characteristics and stability at low temperatures. Opportunities exist in the way applications are extended in the medical aesthetics segment, driven by the increasing demand for safe and easy-to-use injection systems. Major market growth drivers are the growing need for quality, disposable injection devices, technology improvement in polymers that increases syringe performance, and the growing incidence of chronic diseases that require frequent injections. Government programs promoting healthcare infrastructure and technology also contribute to market growth. Topmost manufacturers in Japan, including Terumo Corporation, are playing a pivotal role in the growth of the market and new technology developments.

 

Report Coverage

This research report categorizes the market for the Japan COP and COC syringe market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan COP and COC syringe market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan COP and COC syringe market.

 

Japan COP and COC Syringe Market Report Coverage

Report CoverageDetails
Base Year:2024
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :8.1%
Historical Data for:2020-2023
No. of Pages:220
Tables, Charts & Figures:101
Segments covered:By Product Type, By Application, By End-User and COVID-19 Impact Analysis
Companies covered:: Terumo Corporation, JSR Corporation, Nipro Corporation, SCHOTT AG, Becton, Dickinson and Company (BD), Platinum Pharma Services, Plas-Tech Engineering, Polyplastics Co., Ltd., Vetter Pharma International GmbH, Taisei Medical Co., Ltd., Gerresheimer AG, Others.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis.

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The key drivers for Japan's COP and COC syringe market are the growing demand for high-quality, single-use syringes for drug delivery, particularly biologics and vaccines. The market is facilitated by the syringes' excellence in chemical resistance, heat resistance, and breakage resistance. Growth in the prevalence of chronic diseases, an aging population, and developments in pharmaceutical packaging technologies further improved demand, coupled with government initiatives to improve healthcare infrastructure and promote medical device innovation.

 

Restraining Factors

The market for Japan COP and COC syringes is confronted with constraints in the form of high production prices, scarcity of raw materials, and competition from conventional syringe materials that can deter extensive usage despite their high-end specifications.

 

Market Segmentation

The Japan COP and COC syringe market share is classified into product type, application, and end-user.

 

  • The disposable syringes segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan COP and COC syringe market is segmented by product type into disposable syringes and reusable syringes. Among these, the disposable syringes segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to they are convenient and can reduce cross-contamination risk. They find extensive applications in all medical care environments, such as hospitals, clinics, and home care, and hence are an important market segment.

 

  • The medical segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan COP and COC syringe market is segmented by application into medical, veterinary, laboratory, and others. Among these, the medical segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to the growing need for syringes in hospitals, clinics, and home healthcare environments. Medical syringes are used to administer drugs, vaccines, and other therapeutic drugs, hence a vital element in patient treatment. The growth in the number of chronic diseases like diabetes and cancer requires frequent and accurate drug delivery

 

  • The hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan COP and COC syringe market is segmented by end-user into hospitals, clinics, research laboratories, and others. Among these, the hospitals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the high level of medical procedures and the demand for effective and safe syringe systems. Hospitals need an extensive range of syringes in order to deliver drugs, vaccines, and other therapies to patients.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan COP and COC syringe market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Terumo Corporation
  • JSR Corporation
  • Nipro Corporation
  • SCHOTT AG
  • Becton, Dickinson and Company (BD)
  • Platinum Pharma Services
  • Plas-Tech Engineering
  • Polyplastics Co., Ltd.
  • Vetter Pharma International GmbH
  • Taisei Medical Co., Ltd.
  • Gerresheimer AG
  • Others

 

Recent Developments:

  • In April 2025, Gerresheimer AG, a systems and solutions provider and worldwide partner for pharma, biotech, and cosmetics, now provided end-to-end silicone-oil- and PFAS-free syringe systems of glass and cyclic olefin polymer (COP). The aim is to steer clear of silicone oil and thereby reduce particle load by half, and also reduce possible medical dangers and side effects to a minimum.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan COP and COC syringe market based on the below-mentioned segments:

 

Japan COP and COC Syringe Market, By Product Type

  • Disposable Syringes
  • Reusable Syringes

 

Japan COP and COC Syringe Market, By Application

  • Medical
  • Veterinary
  • Laboratory
  • Others

 

Japan COP and COC Syringe Market, By End-User

  • Hospitals
  • Clinics
  • Research Laboratories
  • Others

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies